Trial Profile
Phase II study evaluating indoximod (1600mg BID) + INGN 225 in patients with metastatic breast cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 12 Jun 2013
Price :
$35
*
At a glance
- Drugs Indoximod (Primary) ; INGN 225 (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 12 Jun 2013 New trial record